Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated:  12/6/2017
Providence St. Joseph
mi
from
Burbank, CA
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated: 12/6/2017
Providence St. Joseph
mi
from
Burbank, CA
Click here to add this to my saved trials
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated:  12/6/2017
UCLA
mi
from
Los Angeles, CA
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated: 12/6/2017
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated:  12/6/2017
Sanford Research
mi
from
Fargo, ND
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated: 12/6/2017
Sanford Research
mi
from
Fargo, ND
Click here to add this to my saved trials
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated:  12/6/2017
MUSC
mi
from
Charleston, SC
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated: 12/6/2017
MUSC
mi
from
Charleston, SC
Click here to add this to my saved trials
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated:  12/6/2017
Swedish Health Services
mi
from
Seattle, WA
Initial Experience With the AngioVac Venous Drainage Cannula
Initial Experience With the AngioVac Venous Drainage Cannula and Cardiopulmonary Bypass Circuit: A Retrospective, Multi-Center Chart Review
Status: Enrolling
Updated: 12/6/2017
Swedish Health Services
mi
from
Seattle, WA
Click here to add this to my saved trials
Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion
Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion
Status: Enrolling
Updated:  12/6/2017
Icahn School of Medicine at Mount Sinai and Mount Sinai Hospital
mi
from
New York, NY
Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion
Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion
Status: Enrolling
Updated: 12/6/2017
Icahn School of Medicine at Mount Sinai and Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Stress Echo Ultrasound Contrast in an Urban Safety Net Hospital to Refine Ischemia Evaluation
Stress Echo Ultrasound Contrast in an Urban Safety Net Hospital to Refine Ischemia Evaluation
Status: Enrolling
Updated:  12/7/2017
Denver Health Medical Center
mi
from
Denver, CO
Stress Echo Ultrasound Contrast in an Urban Safety Net Hospital to Refine Ischemia Evaluation
Stress Echo Ultrasound Contrast in an Urban Safety Net Hospital to Refine Ischemia Evaluation
Status: Enrolling
Updated: 12/7/2017
Denver Health Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease
The Intracoronary Tissue-type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events in Patients With Non-critical Coronary Artery Disease
Status: Enrolling
Updated:  12/11/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease
The Intracoronary Tissue-type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events in Patients With Non-critical Coronary Artery Disease
Status: Enrolling
Updated: 12/11/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Platelet Activity in Vascular Surgery for Thrombosis and Bleeding
Platelet Activity in Vascular Surgery
Status: Enrolling
Updated:  12/12/2017
Bellevue Hospital Center, South Manhattan Healthcare Network
mi
from
New York, NY
Platelet Activity in Vascular Surgery for Thrombosis and Bleeding
Platelet Activity in Vascular Surgery
Status: Enrolling
Updated: 12/12/2017
Bellevue Hospital Center, South Manhattan Healthcare Network
mi
from
New York, NY
Click here to add this to my saved trials
Platelet Activity in Vascular Surgery for Thrombosis and Bleeding
Platelet Activity in Vascular Surgery
Status: Enrolling
Updated:  12/12/2017
New York University School of Medicine
mi
from
New York, NY
Platelet Activity in Vascular Surgery for Thrombosis and Bleeding
Platelet Activity in Vascular Surgery
Status: Enrolling
Updated: 12/12/2017
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Vitamins in Nitrous Oxide Study
Pharmacogenetics of Adverse Outcomes After Nitrous Oxide Anesthesia
Status: Enrolling
Updated:  12/14/2017
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Vitamins in Nitrous Oxide Study
Pharmacogenetics of Adverse Outcomes After Nitrous Oxide Anesthesia
Status: Enrolling
Updated: 12/14/2017
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation II
Status: Enrolling
Updated:  1/2/2018
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II
The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and Inflammation II
Status: Enrolling
Updated: 1/2/2018
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
Status: Enrolling
Updated:  1/2/2018
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention
Status: Enrolling
Updated: 1/2/2018
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Central Arkansas Veterans Healthcare System
mi
from
Little Rock, AR
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Washington Hospital Center, Medstar Research Institute
mi
from
Washington,
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Washington Hospital Center, Medstar Research Institute
mi
from
Washington,
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Jim Moran Heart and Vascular Research Institute
mi
from
Fort Lauderdale, FL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Jim Moran Heart and Vascular Research Institute
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Shands Jacksonville Medical Center (UFL)
mi
from
Jacksonville, FL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Shands Jacksonville Medical Center (UFL)
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Cardiology Research Associates
mi
from
Ormond Beach, FL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Cardiology Research Associates
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Emory University Hospital
mi
from
Atlanta, GA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Advocate Good Shephard Hospital
mi
from
Barrington, IL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Advocate Good Shephard Hospital
mi
from
Barrington, IL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Rush University Medical Center
mi
from
Chicago, IL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
University of Chicago
mi
from
Chicago, IL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Trinity Medical Center
mi
from
Rock Island, IL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Trinity Medical Center
mi
from
Rock Island, IL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Midwest Cardiovascular Research Foundation
mi
from
Davenport, IA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Midwest Cardiovascular Research Foundation
mi
from
Davenport, IA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
University of Kentucky, Gill Heart Institute
mi
from
Lexington, KY
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
University of Kentucky, Gill Heart Institute
mi
from
Lexington, KY
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Henry Ford Hospital, Heart & Vascular Institute
mi
from
Detroit, MI
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Henry Ford Hospital, Heart & Vascular Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Genesys Regional Medical Center
mi
from
Grand Blanc, MI
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Genesys Regional Medical Center
mi
from
Grand Blanc, MI
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Saint Mary's Duluth Clinic Health Center
mi
from
Duluth, MN
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Saint Mary's Duluth Clinic Health Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Minneapolis VA Medical Center
mi
from
Minneapolis, MN
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Minneapolis VA Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Saint-Luke's Hospital / Mid America Heart Institute
mi
from
Kansas City, MO
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Saint-Luke's Hospital / Mid America Heart Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
UNC Health Systems
mi
from
Chapel Hill, NC
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
UNC Health Systems
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Riverside Methodist Hospital
mi
from
Columbus, OH
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Genesis Health Care System
mi
from
Zanesville, OH
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Genesis Health Care System
mi
from
Zanesville, OH
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Black Hills Clinical Research Center
mi
from
Rapid City, SD
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Black Hills Clinical Research Center
mi
from
Rapid City, SD
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Centennial Heart Cardiovascular Consultants, LLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Northwest Texas Healthcare System_Amarillo Heart Clinical Research Institute, Inc.
mi
from
Amarillo, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Northwest Texas Healthcare System_Amarillo Heart Clinical Research Institute, Inc.
mi
from
Amarillo, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Austin Heart, P.A.
mi
from
Austin, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Austin Heart, P.A.
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Plaza Medical Center of Fort Worth
mi
from
Fort Worth, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Plaza Medical Center of Fort Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Methodist Hospital
mi
from
Houston, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Victoria Heart and Vascular Center
mi
from
Victoria, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Providence Health Center
mi
from
Waco, TX
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Providence Health Center
mi
from
Waco, TX
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
UVA Cardiology, UVA Health System
mi
from
Charlottesville, VA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
UVA Cardiology, UVA Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Mcguire Va Medical Center
mi
from
Richmond, VA
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Mcguire Va Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Comprehensive Cardiology Care
mi
from
Milwaukee, WI
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Comprehensive Cardiology Care
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
University of Alberta Hospital, WMC
mi
from
Edmonton,
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
University of Alberta Hospital, WMC
mi
from
Edmonton,
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Suncoast Cardiovascular Research
mi
from
Saint Petersburg, FL
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Suncoast Cardiovascular Research
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated:  1/2/2018
Saint Louis University Hospital
mi
from
Saint Louis, MO
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
A Randomized, Open-label, Parallel Group Feasibility Study to Determine the Safety and Efficacy of M118 vs. Unfractionated Heparin (UFH) in Subjects With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention (PCI)
Status: Enrolling
Updated: 1/2/2018
Saint Louis University Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials